Yanagiya Ryo, Kato Hiroko, Ninomiya Akinori, Ueno Masaya, Kanamori Akane, Miyatake Yuji, Oka Masahiro, Ishii Keisuke, Matsuura Tadashi, Nakagawa So, Hirao Atsushi, Onizuka Makoto, Kotani Ai
Department of Regulation of Infectious Cancers, Research Institute for Microbial Diseases, The University of Osaka, Suita, Japan; Department of Hematology and Oncology, Tokai University School of Medicine, Isehara, Japan; Department of Drug Discovery and Biomedical Sciences, Faculty of Medicine, Saga University, Saga, Japan.
Core Instrumentation Facility, Immunology Frontier Research Center, The University of Osaka, Suita, Japan.
Redox Biol. 2025 Jun 11;85:103727. doi: 10.1016/j.redox.2025.103727.
Iron is essential for neoplasms including natural killer (NK) cell lymphoma, and mainly supplemented by transferrin and stored by ferritin. Although accumulating studies had demonstrated that iron chelation arrests cell cycle progression at G1 phase, our previous studies showed the induction of DNA double strand break at S phase cell cycle without G1 arrest by selective inhibition of cellular transferrin uptake, indicating that the existence of some undiscovered differences in the roles of the two major iron sources for cell cycle regulation. In this study, we identified a novel cell cycle regulation of transferrin binding iron in NK cell lymphoma. Blocking transferrin uptake induced S phase arrest owing to the dysfunction of nascent DNA synthesis. Moreover, canonical G1 arrest was observed with mitochondrial dysfunction followed by downregulation of mTORC1 and dephosphorylation of Rb only when intracellular iron storage was deprived by iron chelation. These results suggested that iron is critically involved in at least two steps of the cell cycle: the S phase and G1/S transition. Especially, considering the toxicity of mitochondrial dysfunction to normal cells and cell cycle dependent manner of S phase-specific DNA damage due to selective inhibition of transferrin uptake, transferrin receptor blockers are thought to be more suitable than iron chelators as antineoplastic agents. Overall, the current canonical model of cell cycle regulation by iron requires revision.
铁对于包括自然杀伤(NK)细胞淋巴瘤在内的肿瘤至关重要,主要通过转铁蛋白补充并由铁蛋白储存。尽管越来越多的研究表明铁螯合可使细胞周期进程停滞在G1期,但我们之前的研究显示,通过选择性抑制细胞转铁蛋白摄取,可在S期细胞周期诱导DNA双链断裂,而不出现G1期停滞,这表明在细胞周期调控中,两种主要铁源的作用存在一些未被发现的差异。在本研究中,我们确定了NK细胞淋巴瘤中转铁蛋白结合铁的一种新型细胞周期调控机制。阻断转铁蛋白摄取会因新生DNA合成功能障碍而导致S期停滞。此外,仅当通过铁螯合剥夺细胞内铁储存时,才会观察到线粒体功能障碍后出现典型的G1期停滞,随后mTORC1下调和Rb去磷酸化。这些结果表明,铁至少在细胞周期的两个步骤中起关键作用:S期和G1/S转换。特别是,考虑到线粒体功能障碍对正常细胞的毒性以及由于选择性抑制转铁蛋白摄取导致的S期特异性DNA损伤的细胞周期依赖性方式,转铁蛋白受体阻滞剂被认为比铁螯合剂更适合作为抗肿瘤药物。总体而言,目前关于铁对细胞周期调控的经典模型需要修正。